Quarterly report pursuant to Section 13 or 15(d)

Debt (Tables)

v3.19.1
Debt (Tables)
3 Months Ended
Mar. 31, 2019
Debt Disclosure [Abstract]  
Schedule of Debt At March 31, 2019 and December 31, 2018, we had notes payable and other debt (excluding the 2033 Senior Notes, the 2023 Convertible Notes, the 2025 Notes, the Credit Agreement and amounts outstanding under lines of credit) as follows:
(In thousands)
March 31,
2019
 
December 31,
2018
Current portion of notes payable
$
2,520

 
$
2,560

Other long-term liabilities
5,288

 
5,693

Total
$
7,808

 
$
8,253

The following table sets forth information related to the 2025 Notes which is included in our Condensed Consolidated Balance Sheet as of March 31, 2019:
(In thousands)
2025 Senior Notes
 
Discount
 
Debt Issuance Cost
 
Total
Balance at December 31, 2018
$

 
$

 
$

 
$

Issuance of 4.50% convertible notes
200,000

 
(52,600
)
 
(5,720
)
 
141,680

Amortization of debt discount and debt issuance costs

 
897

 
97

 
994

Balance at March 31, 2019
$
200,000

 
$
(51,703
)
 
$
(5,623
)
 
$
142,674

Summary of Lines of Credit The following table summarizes the amounts outstanding under the BioReference, Chilean and Spanish lines of credit:
(Dollars in thousands)
 
 
 
 
 
 Balance Outstanding
Lender
 
Interest rate on
borrowings at March 31, 2019
 
Credit line
capacity
 
March 31,
2019
 
December 31,
2018
JPMorgan Chase
 
4.15%
 
$
175,000

 
$
105,280

 
$
105,198

Itau Bank
 
5.50%
 
1,810

 
594

 
232

Bank of Chile
 
6.60%
 
3,800

 
844

 
432

BICE Bank
 
5.50%
 
2,500

 
747

 
818

BBVA Bank
 
5.50%
 
3,250

 
1,168

 
858

Security Bank
 
5.50%
 

 

 

Estado Bank
 
5.50%
 
3,500

 
764

 
308

Santander Bank
 
5.50%
 
4,500

 
524

 
852

Scotiabank
 
5.00%
 
1,800

 
81

 
2

Banco De Sabadell
 
1.45%
 
337

 

 

Banco Bilbao Vizcaya
 
2.64%
 
337

 

 

Banco Santander
 
2.39%
 
337

 
29

 
10

Total
 
 
 
$
197,171

 
$
110,031

 
$
108,710